Based on our results, FOXP3+ tumor infiltrating lymphocytes in OSCC may have a similar inhibitory effect as other solid tumors by inhibiting the cytotoxic activity of CD8+ T cells and affecting the response to immunotherapy. Here, FOXP3 is linked to neoplasm.